Is Organigram Global Inc. (OGI) a Buy, Sell, or Hold?
Organigram Global Inc.
NASDAQ:OGI
$0.8902 USD
-$0.01 (-0.63%)
- Volume
- 726.56K
- Average Volume
- 700.32K
- Market Capitalization
- $125.32M
- P/E Ratio
- -6.79
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $2.24
- Year Low
- $0.85
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.82
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | James H. Yamanaka |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Current Symbol | OGI |
| CUSIP | 68617J100 |
| CIK | 0001620737 |
| Web | https://www.organigram.ca |
| Phone | 15063841571 |
| Currency | USD |
| Employees | 1139 |
| Country | CA |
Liquidity
| Debt-to-Equity Ratio | 0.02 |
| Payout Ratio | 0.00 |
| Current Ratio | 2.82 |
| Quick Ratio | 1.30 |
| Cash Ratio | 0.61 |
Sales & Book Value
| Annual Sales | $186.09M |
| Price / Sales | 0.62 |
| Cash Flow | -0.15 |
| Price / Cash Flow | -8.45 |
| Price / Book | 0.44 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Neutral |
| Rating Score(0-5) | 3 |
| Research Coverage | 5 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-0.14 |
| Trailing P/E Ratio | -6.79 |
| PEG Ratio | -0.01 |
| P/E Growth | -0.01 |
| Net Income | $-17.78M |
| Net Margin | -9.19% |
| Pretax Margin | -14.18% |
| Return on Equity | -6.83% |
| Return on Assets | -4.84% |
Financials Score
| AltmanZ Score | -0.05 |
| Piotroski Score | 2.00 |
| Working Capital | 161.76M |
| Total Assets | 522.66M |
| Ebit | -14.12M |
| Market Cap | 180.92M |
| Total Liabilities | 149.89M |
Poll Results
About Organigram Global Inc. (NASDAQ:OGI) Stock
Organigram Global Inc., primarily operating through its subsidiary Organigram Holdings Inc., is a Canadian enterprise specializing in the cultivation, production, and distribution of cannabis and related products. The company serves the medical cannabis market by offering products such as cannabis flowers, oils, and vaporizing devices to both civilian patients and military veterans. For adult recreational consumers, Organigram provides a diverse range of cannabis products, including edibles and concentrates, under popular brands like Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour. Additionally, the company acts as a wholesale supplier, distributing cannabis plant cuttings, dried flowers, proprietary blends, pre-rolled products, and various cannabis deriva ... tives to retailers and other wholesalers within the adult-use recreational sector. Customers can purchase Organigram's offerings through its online platform or via telephone orders. Established in 2013, the company's corporate headquarters are located in Moncton, Canada.
Organigram: Record Harvests Are The Root Of Market Share Erosion
2026-05-20 07:07:37
Organigram's disappointing Q2 earnings could be a direct result of its record harvests overwhelming downstream capacity. Expected Sanity contribution to full-year revenue and adjusted EBITDA guidance suggests that organic growth may turn negative in the second half of FY 2026. Persistent out-of-spec exports point to a severe bottleneck in drying capacity, where overcrowded drying rooms are fostering microbial growth and driving inconsistent drying.
Organigram Global Inc. (OGI:CA) Q2 2026 Earnings Call Transcript
2026-05-12 15:20:44
Organigram Global Inc. (OGI:CA) Q2 2026 Earnings Call Transcript
Organigram Says Vape Weakness Pressures Margins
2026-05-12 14:30:36
Organigram Global Inc. (NASDAQ:OGI) reported weaker second-quarter fiscal 2026 results as declining vape and infused pre-roll sales weighed on revenue and profitability.
OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates
2026-05-12 10:15:28
OrganiGram (OGI) came out with a quarterly loss of $0.01 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.05 per share a year ago.
Organigram Global Q2 Earnings Call Highlights
2026-05-12 09:07:50
Organigram Global NASDAQ: OGI reported a weaker second quarter for fiscal 2026, with management attributing the decline to operational issues in key product categories, softer Canadian cannabis market growth and continued challenges with international flower specifications.
Organigram Reports Second Quarter Fiscal 2026 Results
2026-05-12 06:00:00
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share1, is pleased to announce its results for the second quarter ended March 31, 2026 (“Q2 Fiscal 2026” or "Q2"). Q2 FISCAL 2026 HIGHLIGHTS Gross Revenue: $93.3 million (-9% year-over-year). Net Revenue: $59.8 million (-9% year-over-year). International Revenue: $6.1 million (0% year-over-year). Adjusted EBITDA2: $0.9 million (-82% year-over-year).
Organigram to Report Second Quarter Fiscal 2026 Results on May 12th, 2026
2026-05-06 06:00:00
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, announced today it will report earnings results for its second quarter fiscal 2026 ended March 31, 2026, on Tuesday, May 12, 2026, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, May 12, 2026 Time: 8:00 am Eastern Time To register for the conference call, please use t.
2026-04-15 12:03:00
TORONTO & BERLIN--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”) and Sanity Group GmbH (“Sanity” or “Sanity Group”) jointly announced the successful closing of Organigram's previously announced acquisition (the “Acquisition”) of Sanity Group, pursuant to the terms of a share purchase agreement dated February 18, 2026 (the “Share Purchase Agreement”). In connection with closing of the Acquisition, a wholly owned subsidiary of the Company acquire.
Frequently Asked Questions
-
What is the current Organigram Global Inc. (OGI) stock price?
-
Organigram Global Inc.(NASDAQ:OGI) stock price is $0.8902 in the last trading session. During the trading session, OGI stock reached the peak price of $2.24 while $0.8549 was the lowest point it dropped to. The percentage change in OGI stock occurred in the recent session was --0.63% while the dollar amount for the price change in OGI stock was -$-0.01.
-
OGI's industry and sector of operation?
-
The NASDAQ listed OGI is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of OGI?
-
Max Schwartz | Director of Investor Relations
Greg Guyatt | Chief Financial Officer
James H. Yamanaka | Chief Executive Officer & Director
Paolo De Luca | Chief Strategy Officer
Peter L. Amirault | Executive Chairman -
How many employees does OGI have?
-
Number of OGI employees currently stands at 1139. OGI operates from 35 English Drive, Moncton, NB E1E 3X3, CA.
-
Link for OGI official website?
-
Official Website of OGI is: https://www.organigram.ca
-
How do I contact OGI?
-
OGI could be contacted at phone #15063841571 and can also be accessed through its website. OGI operates from 35 English Drive, Moncton, NB E1E 3X3, CA.
-
How many shares of OGI are traded daily?
-
The average number of OGI shares traded daily for last 3 months was 700.32K.
-
What is the market cap of OGI currently?
-
The market value of OGI currently stands at $125.32M with its latest stock price at $0.8902